Exercise program for women with triple-negative breast cancer on chemotherapy
Part of Cancer, Skin clinical trials.
This trial tests whether a supervised exercise program can help women with triple-negative breast cancer who are receiving chemotherapy. It may help manage side effects and improve well-being during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with triple-negative breast cancer and will start a specific chemotherapy plan including pembrolizumab.
- Your cancer is at an early stage (T1c and up to 2 lymph nodes involved, or T2-4 with any lymph node involvement).
- You are being treated with the goal of curing the cancer and are expected to live at least 3 months.
- You are not pregnant or breastfeeding and agree to use effective birth control during and for a period after treatment.
- You are able to speak and understand German well enough to follow instructions.
- You have no other cancer in the last 2 years (except some skin cancers) and have not received prior treatment for this breast cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether supervised exercise during chemotherapy is safe and helpful for people with early-stage breast cancer. It may support physical function and well-being while you are receiving cancer treatment.
This study tests whether a healthy lifestyle program (diet and exercise) can help improve the results of breast cancer treatment before surgery. It's for women with triple-negative breast cancer who are getting chemotherapy and immunotherapy.
This trial tests whether a special cycling exercise program during chemotherapy can help women with breast cancer. It is for patients who are about to start a common type of chemotherapy and want to add physical activity to their treatment plan.
This trial studies whether a structured exercise program during pre-surgery chemotherapy can be safely done and may help people feel and function better during treatment. You may join if you have invasive breast cancer and can commit to the exercise plan while on chemotherapy.
This trial tests whether adding the immunotherapy drug pembrolizumab (Keytruda) to standard chemotherapy (carboplatin + paclitaxel) before surgery can improve outcomes for people with early-stage triple-negative breast cancer. It aims to shrink the tumor and increase the chance of a complete response.
This trial tests a new personalized treatment approach (mRNA-lncRNA model) for people with low-risk, early-stage triple-negative breast cancer who have already had surgery. It aims to see if a less intense treatment can work just as well as standard care.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.